Drugs Made In America Acquisition (DMIIR) Total Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMIIR) reported Total Liabilities of $17.8 million for Q4 2025, up 6886.68% year-over-year from $254783.0 in Q4 2024, and down 2.07% on a QoQ basis from $18.2 million in Q3 2025.
Drugs Made In America Acquisition (DMIIR) has 2 years of Total Liabilities data on file, last reported at $17.8 million in Q4 2025.
- Quarterly Total Liabilities rose 6886.68% year-over-year to $17.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.8 million (up 6886.68% YoY) and the FY2025 annual result came in at $17.8 million, up 6886.68% from the prior year.
- Total Liabilities slipped to $17.8 million in Q4 2025 per DMIIR's latest filing, from $18.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $18.2 million in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 18.40 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 12.59 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 13.84 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 11.51 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 29.40 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 16.74 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 9.81 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 14.53 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 9.00 Mn |
| 10 | Drugs Made In America Acquisition | - | - | - | 17.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.80 Mn |
| Sep 30, 2025 | 18.18 Mn |
| Dec 31, 2024 | 254,783.00 |